Link Pharma Chem Intrinsic Value
Link Pharma Chem (LINKPH) median intrinsic value is ₹15.00 from 8 valuation models (range ₹8–₹70), vs current price ₹28.00 — -46.4% downside (Trading Above Calculated Value), margin of safety -86.7%. Analyse LINKPH promoter holding to track promoter, FII and institutional holdings.
LINKPH Valuation Methods Summary — DCF, Graham Number & P/E
Link Pharma Chem intrinsic value across 8 models vs current price ₹28.00 — upside/downside and value range per method. Read LINKPH ex-dividend dates for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹8.40 | ₹6.72 - ₹10.08 | -70.0% | EPS: ₹0.17, Sector P/E: 12x |
| Book Value Method | asset | ₹32.50 | ₹29.25 - ₹35.75 | +16.1% | Book Value/Share: ₹32.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹54.00 | ₹48.60 - ₹59.40 | +92.9% | Revenue/Share: ₹67.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹15.00 | ₹13.50 - ₹16.50 | -46.4% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹69.63 | ₹55.70 - ₹83.56 | +148.7% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹8.40 | ₹7.56 - ₹9.24 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹8.40 | ₹7.56 - ₹9.24 | -70.0% | Revenue Growth: -15.9%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹11.15 | ₹10.04 - ₹12.27 | -60.2% | EPS: ₹0.17, BVPS: ₹32.50 |
LINKPH Intrinsic Value vs Market Price — All Valuation Models
Link Pharma Chem fair value range ₹8–₹70 vs current market price ₹28.00 across 8 valuation models. For current market price and key ratios, visit Link Pharma Chem stock price NSE.
LINKPH Intrinsic Value Analysis — Undervalued or Overvalued?
Link Pharma Chem median intrinsic value ₹15.00, current price ₹28.00 — Trading Above Calculated Value by 46.4%, margin of safety -86.7%.
What is the intrinsic value of LINKPH?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Link Pharma Chem (LINKPH) is ₹15.00 (median value). With the current market price of ₹28.00, this represents a -46.4% variance from our estimated fair value.
The valuation range spans from ₹8.40 to ₹69.63, indicating ₹8.40 - ₹69.63.
Is LINKPH undervalued or overvalued?
Based on our multi-method analysis, Link Pharma Chem (LINKPH) appears to be trading above calculated value by approximately 46.4%.
LINKPH Financial Health — Key Ratios vs Industry Benchmarks
Link Pharma Chem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 11.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.08x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
LINKPH Cash Flow Quality — Operating & Free Cash Flow
Link Pharma Chem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹5 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |